Updates are available Correction dated 2024-09-24
Click to view Correction: https://doi.org/10.1038/s41586-024-08081-w
-
Authors
Lakshmikanth, Tadepally https://orcid.org/0000-0001-7256-5770
Consiglio, Camila https://orcid.org/0000-0002-8901-2328
Sardh, Fabian
Forlin, Rikard
Wang, Jun
Tan, Ziyang
Barcenilla, Hugo https://orcid.org/0000-0002-7255-362X
Rodriguez, Lucie https://orcid.org/0000-0002-3692-9060
Sugrue, Jamie
Noori, Peri
Ivanchenko, Margarita
Piñero Páez, Laura
Gonzalez, Laura
Habimana Mugabo, Constantin
Johnsson, Anette
Ryberg, Henrik
Hallgren, Åsa
Pou, Christian
Chen, Yang
Mikeš, Jaromír https://orcid.org/0000-0002-9941-7855
James, Anna
Dahlqvist, Per https://orcid.org/0000-0002-6471-9503
Wahlberg, Jeanette https://orcid.org/0000-0003-4061-6830
Hagelin, Anders
Holmberg, Mats https://orcid.org/0000-0003-2884-9981
Degerblad, Marie
Isaksson, Magnus
Duffy, Darragh https://orcid.org/0000-0002-8875-2308
Kämpe, Olle https://orcid.org/0000-0001-6091-9914
Landegren, Nils
Brodin, Petter https://orcid.org/0000-0002-8103-0046
- License Information
-
More Information
Article History
Received: 6 April 2023
Accepted: 4 July 2024
First Online: 4 September 2024
Change Date: 24 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41586-024-08081-w
Competing interests
: P.B., T.L. and J.M. are cofounders of Cytodelics AB (Stockholm, Sweden), which produces and distributes the whole blood cell stabilizer solutions used in this study. P.B. is an executive board member of Kancera AB, scientific advisor for Pixelgen Technologies AB, Helaina Inc., Scailyte AG, Oxford Immune Algorithmics Ltd, Sention Health AB and the Swedish Olympic Committee. The other authors declare no competing interests.
